AGY — Allergy Therapeutics Share News
0.000.00%
- £706.27m
- £753.56m
- £55.04m
REG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG-River and Mercantile Asset Management LLP Form 8.3 - The Allergy Therapeutics Plc
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - ZQ Capital Limited Allergy Therapeutics - Statement Regarding Possible Mandatory Cash Offer
AnnouncementREG - Allergy Therapeutics - £40.75 million Facility with Equity Financing
AnnouncementREG - Allergy Therapeutics - Trading and Business Update
AnnouncementREG - Allergy Therapeutics - Publication of Interim Results Delayed
AnnouncementREG - Allergy Therapeutics - Patients dosed in VLP Peanut PROTECT trial
AnnouncementREG - Allergy Therapeutics - Block Listing Interim Review
AnnouncementRCS - Allergy Therapeutics - PDMR Dealing
AnnouncementREG - Allergy Therapeutics - Result of AGM
Announcement